Attached files
| file | filename |
|---|---|
| EX-99.1 - China Botanic Pharmaceutical | v206306_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): December 16, 2010
CHINA
BOTANIC PHARMACEUTICAL INC.
(Exact
name of Registrant as Specified in its Charter)
|
Nevada
|
0-24512
|
88-1273503
|
||
|
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
No.
281, Taiping Road, Taiping District
Harbin,
Heilongjiang Province, 150050
(Address
of Principal Executive Offices)
Registrant’s
telephone number, including area code: 86-451-5762-0378
N/A
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
ITEM 5.02.
APPOINTMENT OF CERTAIN OFFICERS.
(c)
On December 16, 2010, the Company announced that Mr. David (Weiqiu) Dong, age
40, was appointed to the position of Chief Financial Officer. Since September
2006, Mr. Dong has been an Investment Manager with Hatitac Inc., an
investment manager with in excess of $5,000,000 under management, and Mr. Dong
was responsible for financial planning, risk management, tax planning and
company accounting services. From March 2006 to October 2008, Mr. Dong was an
investment manager with HUB International, an investment manager with over
$3,000,000 under management. From September 2000 to February 2006,
Mr. Dong was an Investment Manager with Freedom 55 Financial, an investment
manager with over $2,000,000 under management. From March 1998
to April 2000, Mr. Dong was a Senior Audit Manager with TianHua Accounting Firm,
an accounting and tax services firm, and Mr. Dong was responsible for
supervising and performing annual audits, tax and acquisition reviews of
publicly listed companies and private companies. Mr. Dong is a
Certified Financial Planner and received a Bachelor Degree of Engineering from
North-western Polytechnic University, Xi’an, China.
In conjunction with his employment,
Mr. Dong executed an employment agreement, effective December 16,
2010, with the Company, pursuant to which he agreed to serve as the Chief
Financial Officer of the Company. The agreement provides that Mr.
Dong will receive an annual base salary of RMB 600,000 per year. In
accordance with the appointment, Mr. Dong received, on December 16, 2010, an
option to purchase 200,000 shares of the Company's common stock. The
option has a six (6) year term and vests 60,000 shares on the first anniversary
of the date of grant and 70,000 shares on each of the second and third
anniversaries of the date of grant. The exercise price of the option is $2.12,
the closing price on the date of the grant (i.e., December 16, 2010). The
employment agreement included provisions related to confidentiality,
non-competition, non-solicitation and non-disparagement.
Additional information regarding the
foregoing change is contained in the press release attached hereto as Exhibit
99.1.
Item 9.01(d).
Financial Statements and Exhibits.
|
Exhibit
No.
|
Description
|
|
|
99.1
|
Press
Release dated December 16,
2010
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
RENHUANG
PHARMACEUTICALS, INC.
|
|||
|
Date:
December 22, 2010
|
By:
|
/s/
Shaoming Li
|
|
|
Shaoming
Li
|
|||
|
Chief
Executive Officer
|
|||
EXHIBIT
INDEX
|
Exhibit
|
||
|
Number
|
Description
|
|
|
99.1
|
Press
Release dated December 22,
2010
|